Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Calypte Oral HIV Test Nears SFDA Approval

publication date: Jan 24, 2008

Calypte Biomedical Corporation reported that its fast, oral HIV diagnostic test has passed the technical review part of the SFDA approval process for use in China. The Aware™ HIV-1/2 OMT, which tests for both HIV-1 and HIV-2, now has just one aspect of the approval process left before final approval: it must prove that it is in conformity with the regulations for products standards and labeling. More details... 

Stock Symbol: (OTCBB: CBMC) 



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital